Search research articles
Contact Us
Filters
Showing results (71-80 of 220) with videos related to
Page
of 22
Sort By:
The Journal of Biological Chemistry
|
May 17, 2002
Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor
Anita T Stauffer, Mascha K Rochat, Bernhard Dick, et al.
Toxicology Letters
|
February 23, 2025
Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation
Jacek Kȩdzierski, Rianne E van Diest, Julien A Allard, et al.
Molecular and Cellular Endocrinology
|
September 10, 2008
11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose
Anna A Dzyakanchuk, Zoltán Balázs, Lyubomir G Nashev, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
October 6, 2023
A battery of in silico models application for pesticides exerting reproductive health effects: Assessment of performance and prioritization of mechanistic studies
Serhii Kolesnyk, Mykola Prodanchuk, Petro Zhminko, et al.
Nutrients
|
April 27, 2017
Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
Balázs Legeza, Paola Marcolongo, Alessandra Gamberucci, et al.
Chemical Research in Toxicology
|
April 1, 2015
Steroidomic Footprinting Based on Ultra-High Performance Liquid Chromatography Coupled with Qualitative and Quantitative High-Resolution Mass Spectrometry for the Evaluation of Endocrine Disrupting Chemicals in H295R Cells
David Tonoli, Cornelia Fürstenberger, Julien Boccard, et al.
Molecular and Cellular Endocrinology
|
April 23, 2003
Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+
Peter Arnold, Steven Tam, Lisa Yan, et al.
Pharmaceutical Research
|
February 6, 2019
The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic Antibodies
Jerome Egli, Tilman Schlothauer, Christian Spick, et al.
Journal of the American Society of Nephrology : JASN
|
November 23, 2007
DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins
Zoltan Balazs, Roberto A S Schweizer, Felix J Frey, et al.
Cancer Medicine
|
August 28, 2015
A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer
Julia K Seibert, Luca Quagliata, Cristina Quintavalle, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 220) with videos related to
Sort By:
Page
of 22
The Journal of Biological Chemistry
|
May 17, 2002
Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor
Anita T Stauffer, Mascha K Rochat, Bernhard Dick, et al.
Toxicology Letters
|
February 23, 2025
Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation
Jacek Kȩdzierski, Rianne E van Diest, Julien A Allard, et al.
Molecular and Cellular Endocrinology
|
September 10, 2008
11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose
Anna A Dzyakanchuk, Zoltán Balázs, Lyubomir G Nashev, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
October 6, 2023
A battery of in silico models application for pesticides exerting reproductive health effects: Assessment of performance and prioritization of mechanistic studies
Serhii Kolesnyk, Mykola Prodanchuk, Petro Zhminko, et al.
Nutrients
|
April 27, 2017
Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
Balázs Legeza, Paola Marcolongo, Alessandra Gamberucci, et al.
Chemical Research in Toxicology
|
April 1, 2015
Steroidomic Footprinting Based on Ultra-High Performance Liquid Chromatography Coupled with Qualitative and Quantitative High-Resolution Mass Spectrometry for the Evaluation of Endocrine Disrupting Chemicals in H295R Cells
David Tonoli, Cornelia Fürstenberger, Julien Boccard, et al.
Molecular and Cellular Endocrinology
|
April 23, 2003
Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+
Peter Arnold, Steven Tam, Lisa Yan, et al.
Pharmaceutical Research
|
February 6, 2019
The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic Antibodies
Jerome Egli, Tilman Schlothauer, Christian Spick, et al.
Journal of the American Society of Nephrology : JASN
|
November 23, 2007
DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins
Zoltan Balazs, Roberto A S Schweizer, Felix J Frey, et al.
Cancer Medicine
|
August 28, 2015
A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer
Julia K Seibert, Luca Quagliata, Cristina Quintavalle, et al.
Page
of 22